FDA Investigator Mary Jeanet Mcgarry

Mary Jeanet Mcgarry has conducted inspections on 88 sites in 3 countries as of 21 Jun 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
88
Last Inspection Date:
21 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Australia, Canada
FDA Investigators that have inspected at least one site in common with Mary Jeanet Mcgarry:
Abby E Pelletier, Abdollah Koolivand, Abdur Rafay Shareef, Aireen V Mendoza, Alan R Condon, Alice C Silva, Allison A Rodriguez, Almaris N Alonso, Alysia M Salonia, Amber G Wardwell, Amy C Jordan, Andrew M Barlow, Anita R Michael, Anne Marie Dubrey, Anthony C Warchut, Arie C Menachem, Ashley M Whitehurst, Atricia L Irons, Barbara G Swan, Bo Chi, PhD, Bonita S Chester, Brandon C Heitmeier, Brenda P King, Brenda W Uratani, PhD, Brenna L Macdowell, Bryan L Mcguckin, Byungja E Marciante, Camerson E Moore, Candace Y Gomez Broughton, Carla C Tuite, Carla E Lavallee, Cassandra L Abellard, Charisse K Green, Charles A Snipes, PhD, Charles D Brown, Charles R Bonapace, PhD, Charles Yuanchia Kuo, PhD, Christopher Janik, Christopher K Vantwuyver, Christopher M Jenner, Clifton L Randell, Clinton V Giustra, Constance Desimone, Constance Y Fears, Courtney N Long, Cynthia Jim, CSO, Dana A Razzano, Daniel L Zheng, Danielle S Pearson, Darin S Wiegers, Daryl A Dewoskin, David P Vanhouten, Dawn M Braswell, Demario L Walls, Desiree D Clark, Diane C Thibodeau, Diane P Goyette, Dien N Nguyen, Dogbeda F Mackenzie, Dolores Harper, Donald C Obenhuber, PhD, Dongping Dai, PhD, Dorothy W Lee, Douglas S Joslin, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Robert C Horan, MD, Dr. Zhou Chen (nmi), MD PhD, Edmund F Mrak, Jr, Ellen P Madigan, Erich P Garger, Frank J Koch, Frank Wackes, Gam S Zamil, Garry H Stewart, Gary J Hagan, Gena M Mckahan, George T Allen, Jr, Gerard D Difiore, Gunneet Kaur, Haley H Seymour, Intkhab H Wahla, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, Jamie L Port, Jared P Stevens, Jason A Rossi, Jawaid Hamid, Jennifer D Hollstrom, Jessica L Pressley, Jianming Li, Joan A Loreng, John A Sciacchitano, John L Zaccone, John P Mistler, John S Hartford, Jonathan B Lewis, Jonathan G Matrisciano, Joppie, Jose A Lopez, Joseph H Procopio, Jr, Joyce A Kellett, Juanita P Versace, June P Page, Justine M Corson, Kalavati Suvarna, PhD, Kemejumaka N Opara, Kenneth H Williams, Kent A Conforti, Kim Lthomas Cruse, L Norwood, Larry K Hampton, Lauren M Lawrance, Laurie Graham, LCDR Debra Emerson, Leanna M Slarsky, Leo B Zadecky, Lewis K Antwi, Liz M Otero, Lori A Holmquist, Lori M Newman, Louis Christy, M Pedgen, Margaret L Bolte, Margaret M Annes, Margaret M Doherty, Margaret M Sands, Mariza M Jafary, Mark A Heard, Mark R Mcclain, Marlene G Swider, Martin J Guardia, Matthew C Watson, Maura Rooney, Maya M Davis, Megan A Haggerty, Melanie M Walker, Melinda Lee, Michael P Anthony, Michael P Sweeney, Michael R Klapal, Michael Serrano, Michelle M Noe Varga, Michelle Yclark Stuart, Miguel A Martinez Perez, Mihaly S Ligmond, Mikayla K Deardorff, Mindy M Chou, Nabil Nakhoul, Narong Chamkasem, PhD, Nichole B Murphy, Nicole A Lloyd, Noreen Muñiz, Obinna R Echeozo, Pamela L Lee, Pamela L Ogonowski, Pankaj H Amin, Paraluman S Leonin, Patricia F Hughes, PhD, Paul P Geraci, Pete Amin (Pankaj), Philip F Istafanos, DMV, MS, Philip Kreiter, Phillip E Mclaughlin, Postelle Birch Smith, Priscilla M Pastrana, Rachael L Cook, Rachael O Oyewole, Ramcharan S Khalsa, Ramon E Martinez, Ranjani Prabhakara, Rashmi Rawat, PhD, Richard B Mcaroy, Richard F Hapke, Richard H Penta, Richard L Friedman, Robert D Tollefsen, Robert J Martin, Robert O'brian, Rory K Geyer, Rose Ashley, Rupa Pradhan, Salvatore N Randazzo, Samuel K Mathew, Samuel Mathew, Sandra A Hughes, Sandra P White, Santiago Gallardo Johnson, Sara M Onyango, Satheesh Thomas, Saundrea A Munroe, Sayeeda Hdabe, Scott C Lute, Scott R Nichols, PhD, Sean R Marcsisin, Seneca D Toms, Seth A Mailhot, Sharna D Pratt, Slater K Bartlett, Song Y Lavalais, Sonya M Edmonds, Stacey S Degarmo, Stephen C Smith, Stephen J Mottola, Stephen R Souza, Sunita Pandey, Susanne M Richardson, MS RAC, Suzanne M Healy, Svetlana A Shestopal, Sylvia A Craven, Tajah L Blackburn, Terry Bridgewater, Thomas J Arista, Thomas J Murphy, Thomas Siebertz, Thomas W Nerney, Tonia F Bernard, Troy R Petrillo, Uttaniti Limchumroon (Tom), Victor J Gangi, Victoria M Daddeo, Vijaya L Simhadri, Vincent Thomas, Wayne E Seifert, William J Leonard, Ying Xin Fan, PhD, Yumi J Hiramine, Yvonne Y Wu, Zakaria I Ganiyu

Mary Jeanet Mcgarry's Documents

Publish Date Document Type Title
September, 2011 FDA 483 Labcorp Bedford LLC. - Form 483, 2011-09-23
December, 2011 FDA 483 Lymol Medical Corporation - Form 483, 2011-12-15
January, 2013 FDA 483 Regional Home Care, Inc. - Form 483, 2013-01-29
February, 2023 FDA 483 Response Nephron Sterile Compounding Center, LLC - Form 483R, 2023-03-06
November, 2012 FDA 483 Ameridose, LLC - Form 483, 2012-11-09
January, 2016 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2016-01-29
September, 2013 FDA 483 Lonza Biologics, Inc. - Form 483, 2013-09-30
July, 2023 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2023-07-31
May, 2013 EIR Asentral Inc. IRB - EIR, 2013-05-14
February, 2023 FDA 483 Nephron Sterile Compounding Center, LLC - Form 483, 2023-02-10
September, 2014 FDA 483 Marlborough Hospital - Form 483, 2014-09-17
September, 2013 EIR Lonza Biologics, Inc. - EIR, 2013-09-30
January, 2013 EIR Regional Home Care, Inc. - EIR, 2013-01-29
January, 2012 FDA 483 Shire Human Genetic Therapies, Inc. - Form 483, 2012-01-06
August, 2014 FDA 483 Johnson Memorial Cancer Center - Form 483, 2014-08-05
June, 2012 FDA 483 Armstrong Pharmaceuticals, Inc. - Form 483, 2012-06-14
January, 2015 FDA 483 Cambridge Isotope Laboratories, Inc. - Form 483, 2015-01-07
November, 2014 FDA 483 Genzyme Corporation - Form 483, 2014-11-21
August, 2015 FDA 483 Shire Human Genetic Therapies, Inc. - Form 483, 2015-08-14
August, 2012 FDA 483 Shire Human Genetic Therapies, Inc. - Form 483, 2012-08-31
July, 2011 FDA 483 Dyax Corp. - Form 483, 2011-07-08
July, 2014 FDA 483 Cubist Pharmaceuticals, Inc. - Form 483, 2014-07-10
January, 2014 FDA 483 Azurity Pharmaceuticals, Inc. - Form 483, 2014-01-29
January, 2012 EIR Shire Human Genetic Therapies, Inc. - EIR, 2012-01-06
March, 2012 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2012-03-13
April, 2011 FDA 483 Cardea Technology, Inc - Form 483, 2011-04-29
March, 2014 FDA 483 The Dodge Company, Inc. - Form 483, 2014-03-25
October, 2014 FDA 483 ARIAD Pharmaceuticals - Form 483, 2014-10-16
March, 2013 FDA 483 Citius Pharmaceuticals, Inc. - Form 483, 2013-03-14

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more